Worldwide differences in primary prevention implantable cardioverter defibrillator utilization and outcomes in hypertrophic cardiomyopathy.
Nauffal V, Marstrand P, Han L, Parikh VN, Helms AS, Ingles J, Jacoby D, Lakdawala NK, Kapur S, Michels M, Owens AT, Ashley EA, Pereira AC, Rossano JW, Saberi S, Semsarian C, Ware JS, Wittekind SG, Day S, Olivotto I, Ho CY.
Nauffal V, et al. Among authors: owens at.
Eur Heart J. 2021 Oct 7;42(38):3932-3944. doi: 10.1093/eurheartj/ehab598.
Eur Heart J. 2021.
PMID: 34491319
Free PMC article.